BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25104331)

  • 1. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
    Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
    Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
    Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
    Dreyer JH; Hauck F; Barros MHM; Niedobitek G
    Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-associated p16 INK4A expression and response to therapy and survival in selected head and neck cancers.
    Kanyilmaz G; Ekinci O; Muge A; Celik S; Ozturk F
    Asian Pac J Cancer Prev; 2015; 16(1):253-8. PubMed ID: 25640361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of evidence of human papillomavirus-induced squamous cell carcinomas of the oral cavity in southern Germany.
    Reuschenbach M; Kansy K; Garbe K; Vinokurova S; Flechtenmacher C; Toth C; Prigge ES; Thiele OC; Reinert S; Hoffmann J; von Knebel Doeberitz M; Freier K
    Oral Oncol; 2013 Sep; 49(9):937-942. PubMed ID: 23608471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma.
    Gheit T; Abedi-Ardekani B; Carreira C; Missad CG; Tommasino M; Torrente MC
    J Med Virol; 2014 Apr; 86(4):642-6. PubMed ID: 24374907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
    Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
    Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.